Report / Trial registry metadata
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
A registered study record. Recorded registry status: NOT_YET_RECRUITING. A registry entry is not a treatment recommendation or proof that a study succeeded.
Limits
No clinical review has been performed. This record is not a treatment recommendation, eligibility confirmation or current availability guarantee.
- Kind
- Trial registry metadata
- Status
- NOT_YET_RECRUITING